Aims: To observe the clinical effect of acupuncture plus acupoint injection of Acidi Nucleici et Caseini Hydrolysatis Composita in the treatment of allergic rhinitis. Methods: Ninety five cases of allergic rhinitis pa...Aims: To observe the clinical effect of acupuncture plus acupoint injection of Acidi Nucleici et Caseini Hydrolysatis Composita in the treatment of allergic rhinitis. Methods: Ninety five cases of allergic rhinitis patients were randomized into acupuncture plus acupoint injection group (treatment group, n=40), acupuncture group (control group A, n=30) and muscular injection group (control group B, n=25). Yingxiang (LI 20), Yintang (EX HN 3), Baihui (GV 20), Fengchi (GB 20), Fengmen (BL 12), Feishu (BL 13), etc. were used. Results: Following 20 days’ treatment, of the 40, 30 and 25 cases of allergic rhinitis in treatment, control A and B groups, 16 (40.0%), 8 (26.7%) and 0 were cured, 22 (55.0%), 14 (46.7%) and 4 (16.0%) experienced improvement in their symptoms and signs, and 2 (5.0%), 8 (26.7%) and 21 (84.0%) failed in the treatment, with the effective rates being 95.0%, 73.3% and 16.0% separately. The therapeutic effect of treatment group was significantly superior to those of two control groups (P<0.05, 0.01). Conclusion: The therapeutic effect of acupuncture plus acupoint injection of Injecto Acidi Nucleici et Caseini Hydrolysatis Composita is definite.展开更多
文摘Aims: To observe the clinical effect of acupuncture plus acupoint injection of Acidi Nucleici et Caseini Hydrolysatis Composita in the treatment of allergic rhinitis. Methods: Ninety five cases of allergic rhinitis patients were randomized into acupuncture plus acupoint injection group (treatment group, n=40), acupuncture group (control group A, n=30) and muscular injection group (control group B, n=25). Yingxiang (LI 20), Yintang (EX HN 3), Baihui (GV 20), Fengchi (GB 20), Fengmen (BL 12), Feishu (BL 13), etc. were used. Results: Following 20 days’ treatment, of the 40, 30 and 25 cases of allergic rhinitis in treatment, control A and B groups, 16 (40.0%), 8 (26.7%) and 0 were cured, 22 (55.0%), 14 (46.7%) and 4 (16.0%) experienced improvement in their symptoms and signs, and 2 (5.0%), 8 (26.7%) and 21 (84.0%) failed in the treatment, with the effective rates being 95.0%, 73.3% and 16.0% separately. The therapeutic effect of treatment group was significantly superior to those of two control groups (P<0.05, 0.01). Conclusion: The therapeutic effect of acupuncture plus acupoint injection of Injecto Acidi Nucleici et Caseini Hydrolysatis Composita is definite.
